A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/1998
11/03/1998	US5831094 Difluoro statone antiviral analogs
11/03/1998	US5831086 Crystal structure
11/03/1998	US5830920 Prevention growth of smooth muscle cells
11/03/1998	US5830898 Enantiomerically pure β-di-dioxolane-nucleosides with selective anti-hepatitis B virus activity
11/03/1998	US5830894 Methods for preventing and treating pestivirus infection and associated diseases
11/03/1998	US5830889 Antibiotic in oral dosage forms
11/03/1998	US5830867 Hemoregulatory peptides for stimulating the myelopoietic system
11/03/1998	US5830717 Process for production of tricyclo compounds with streptomyces
11/03/1998	US5830634 Aids diagnosis, screening blood doners
11/03/1998	US5830464 Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
11/03/1998	US5830463 Yeast-based delivery vehicles
11/03/1998	US5830455 Method of treatment using a therapeutic combination of α interferon and free radical scavengers
10/1998
10/30/1998	CA2231748A1 Novel g-protein coupled receptor (hfgan72x)
10/30/1998	CA2231741A1 Novel g-protein coupled receptor (hfgan72y)
10/29/1998	WO1998048026A1 Attenuated salmonella strain used as a vehicle for oral immunization
10/29/1998	WO1998048018A1 Recombinant human beta interferon with enhanced solubility
10/29/1998	WO1998048017A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
10/29/1998	WO1998047895A1 2-OXO-1-AZETIDINE SULFONIC ACID DERIVATIVES AS POTENT β-LACTAMASE INHIBITORS
10/29/1998	WO1998047854A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998	WO1998047530A2 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines
10/29/1998	WO1998047374A1 Topical use of probiotic bacillus spores to prevent or control microbial infections
10/29/1998	WO1998039426A3 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
10/29/1998	WO1998033470A3 Substituted perylenequinones for use in photodynamic therapy
10/29/1998	WO1998021233A3 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
10/29/1998	DE19717864A1 Humanes rekombinantes Interferon-beta mit verbesserter Löslichkeit Human recombinant interferon-beta with improved solubility
10/29/1998	CA2288267A1 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines
10/29/1998	CA2287451A1 Topical use of probiotic bacillus spores to prevent or control microbial infections
10/29/1998	CA2286681A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998	CA2286210A1 Attenuated salmonella strain used as a vehicle for oral immunization
10/28/1998	EP0874053A2 3-Dehydroquinate synthase (aroB)
10/28/1998	EP0874051A2 OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines.
10/28/1998	EP0873997A1 Teicoplanin derivatives
10/28/1998	EP0873996A1 Process of deacylation of teicoplanin and product thereby obtained
10/28/1998	EP0873755A1 Prevention and treatment of enterohemorrhagic E. coli infection
10/28/1998	EP0873752A2 Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine
10/28/1998	EP0873519A1 Hiv protease inhibitors
10/28/1998	EP0873414A1 Galactopyranosides and their use
10/28/1998	EP0873409A1 Equine rhinovirus 1 proteins
10/28/1998	EP0873362A1 PROCESS FOR ISOLATING IgG AND IgA
10/28/1998	EP0873355A1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione
10/28/1998	EP0873340A1 Heterocyclic substituted cyclopentane compounds
10/28/1998	EP0873315A1 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives
10/28/1998	EP0873295A1 Dimer-selective rxr modulators and methods for their use
10/28/1998	EP0873140A2 Immunoconjugate for the treatment of aids
10/28/1998	EP0873117A1 Hemoregulatory compounds
10/28/1998	EP0656887B1 Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/28/1998	EP0634436B1 Sulfate of n-acetylneuraminic acid homopolymer, process for producing the same, anti-hiv drug containing said sulfate, method of treating aids with said sulfate, use of said sulfate for treating aids, and use of said sulfate for producing the drug
10/28/1998	EP0596917B1 Benzimidazole anthelmintics
10/28/1998	CN1197457A Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings
10/28/1998	CN1197394A Compsns. and methods for catalyzing hydrolysis of HIV gp120
10/28/1998	CN1197077A Nucleic acid construct for cell cycle regulated expression of structural genes
10/28/1998	CN1196956A Influenza vaccine
10/28/1998	CN1196931A Aqueous solvent based encapsulation of bovine herpes virus type-1 subunit vaccine
10/28/1998	CN1040433C Azole compounds, their prodn. and use
10/27/1998	US5827895 Inhibiting the infection of staphylococcus or mycobacterium by administering a cyclohexane-diketone-diols; anticarcinogenic agents
10/27/1998	US5827891 For treatment of aids, blocking replication of hiv virus
10/27/1998	US5827881 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity
10/27/1998	US5827859 HIV protease inhibitors
10/27/1998	US5827858 Administered to treat aids
10/27/1998	US5827857 Pyrido-fused thienyl- and furanyl-oxazolidinones
10/27/1998	US5827829 Use of a hymenoptera venom for the manufacture of a medicament for treating DNA virus infections
10/27/1998	US5827816 Bactericide for gram-negative bacteria infection; a polypeptide with a cysteine at position 132 replaced by different amino acid
10/27/1998	US5827738 Sustainable chick cell line infected with Marek's disease virus
10/27/1998	US5827723 Neutralizing monoclonal antibody 0.5β which binds an epitope located within the region of amino acids 308-331 of HTLVIIB gp120
10/27/1998	US5827708 Nucleotide sequence which codes for the polypeptide expressed by transfer ribonucleic acid synthetase gene; screening for antibacterial compounds; from genetically enginered cells
10/27/1998	US5827703 Methods and composition for in vivo gene therapy
10/27/1998	US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology
10/27/1998	US5827666 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
10/27/1998	US5827647 Treating samples with isolated empty parvovirus capsids, then detecting antigen-antibody complexes for diagnosis, also kits
10/27/1998	US5827519 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use
10/27/1998	CA2078694C Hepatitis b vaccine
10/27/1998	CA1340103C Cloning of dna for protozoal antigens
10/27/1998	CA1340100C Polynucleotide commposition and method
10/23/1998	CA2235457A1 Prevention and treatment of enterohemorrhagic e. coli infection
10/23/1998	CA2229430A1 Aqueous solvent based encapsulation of bovine herpes virus type-1 subunit vaccine
10/22/1998	WO1998046761A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
10/22/1998	WO1998046743A1 Novel ldl-receptor
10/22/1998	WO1998046732A1 Controlled dissolution cross-linked protein crystals
10/22/1998	WO1998046648A1 Interactive system for substance presentation and elimination
10/22/1998	WO1998046630A1 Hepatitis c ns3 protease inhibitors
10/22/1998	WO1998046606A1 Novel compounds
10/22/1998	WO1998046604A1 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds
10/22/1998	WO1998046603A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998	WO1998046602A1 Alkaloid halide salts of swainsonine and methods of use
10/22/1998	WO1998046580A1 Deacylation process and product
10/22/1998	WO1998046579A1 Teicoplanin derivatives
10/22/1998	WO1998046270A2 Polymeric conjugates polyvalently presenting an agent for therapy
10/22/1998	WO1998046261A1 Vaginal lactobacillus medicant
10/22/1998	WO1998046260A1 Pasteurella haemolytica vaccine
10/22/1998	WO1998046247A1 Solid phase synthesis of immunosuppressive agents
10/22/1998	WO1998046241A1 A combination therapy for hiv infections
10/22/1998	WO1998046239A1 Extended release formulations of erythromycin derivatives
10/22/1998	WO1998046222A1 Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment
10/22/1998	WO1998046213A1 Cefadroxil monohydrate tablet formulation
10/22/1998	WO1998046077A1 A method for treating papillomavirus infections
10/22/1998	WO1998031399A3 Labelled factor xiiia substrates
10/22/1998	DE19749973C1 New T4 lysozyme polypeptide compounds
10/22/1998	CA2287465A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998	CA2286692A1 Polymeric conjugates polyvalently presenting an agent for therapy
10/22/1998	CA2286592A1 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds

1 ... 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 ... 1798